SCHEMBL1055378

SCHEMBL1055378

O=C(O)CN1C(=O)C=CC1=O.O=C1CCC(=O)N1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.43
PTGS1 P23219 5/20 0.41
PTGS2 P35354 5/20 0.41
GSK3A P49840 2/20 0.41
GSK3B P49841 2/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.36
GAA P10253 1/20 0.35
ALDH1A1 P00352 2/20 0.35
GMNN O75496 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
THPO P40225 1/20 0.34
BLM P54132 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL515800 0.84 PTGS1 (0.52) TSHRPTGS1PTGS2GSK3AGSK3B
SCHEMBL1069132 0.82 PTGS1 (0.54) PTGS1PTGS2GSK3AGSK3BMEN1
Hydrochloric Acid SCHEMBL28991159 0.82 PTGS1 (0.50) TSHRPTGS1PTGS2GSK3AGSK3B
SCHEMBL4952666 0.80 PTGS1 (0.65) PTGS1PTGS2GSK3AGSK3BMEN1
Ethylene Glycol SCHEMBL28669577 0.78 PTGS1 (0.47) TSHRPTGS1PTGS2GSK3AGSK3B
Succinimide SCHEMBL27157818 0.78 TSHR (0.43) TSHRPTGS1PTGS2GSK3AGSK3B
SCHEMBL2111664 0.77 PTGS1 (0.76) PTGS1PTGS2GSK3AGSK3BMEN1
Alcohol SCHEMBL29133233 0.76 GSK3A (0.55) TSHRPTGS1PTGS2GSK3AGSK3B
SCHEMBL236431 0.75 TSHR (0.56) TSHRGSK3AGSK3BMEN1KMT2A
1,4-Butanediol SCHEMBL5570451 0.75 PTGS1 (0.48) TSHRPTGS1PTGS2GSK3AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109790171-B Pyrrolobenzodiazepine dimer precursors and ligand-linker conjugate compounds thereof 乐高化学生物科学股份有限公司 2022-07-26 CN disclosed
CN-112040951-A Antibody Drug Conjugates (ADC) with NAMPT inhibitors 拜耳股份公司 2020-12-04 CN disclosed
CN-111565707-A Devices and methods for delivering therapeutics 森玛治疗公司 2020-08-21 CN disclosed
CN-103130895-A Specific binding members against synaptophysin UNIV ABERDEEN 2013-06-05 CN disclosed
EP-1735347-B1 SPECIFIC BINDING MOLECULES AGAINST SYNAPTOPHYSIN UNIV ABERDEEN (GB) 2012-11-07 EP disclosed
US-20110165078-A1 SPECIFIC BINDING MEMBERS AGAINST SYNAPTOPHYSIN THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) 2011-07-07 US disclosed
US-7871782-B2 Specific binding members against synaptophysin THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) 2011-01-18 US disclosed
US-20080274123-A1 Specific Binding Members Against Synaptophysin The University Court of the University of Aberdee n (GB) 2008-11-06 US disclosed
CN-1980958-A Specific binding members against synaptophysin UNIV ABERDEEN (GB) 2007-06-13 CN disclosed
EP-1735347-A2 SPECIFIC BINDING MEMBERS AGAINST SYNAPTOPHYSIN The University Court of The University of Aberdeen (GB) 2006-12-27 EP disclosed
WO-2005095453-A2 SPECIFIC BINDING MEMBERS AGAINST SYNAPTOPHYSIN THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) 2005-10-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110165078-A1 SPECIFIC BINDING MEMBERS AGAINST SYNAPTOPHYSIN SYPL1, IGSF11, VSIR TSHR 3312/4885PTGS1 4765/4885PTGS2 4846/4885
US-20080274123-A1 Specific Binding Members Against Synaptophysin SYPL1, IGSF11, VSIR TSHR 3304/4885PTGS1 4756/4885PTGS2 4846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.